• Itraconazole: Triazole Antifungal Research Guide

  2026-09-29

  Itraconazole is a triazole antifungal agent with activity against Candida species and utility in CYP3A4-focused antifungal drug interaction studies. Its research value also includes investigation of Candida biofilm resistance, hedgehog signaling, and angiogenesis inhibition.

• Coumestrol: From ER Antagonism to Ferroptosis

  2026-09-29

  Coumestrol is more than a phytoestrogen estrogen receptor antagonist: it is a mechanistically informative research compound linking estrogen receptor signaling pathway biology with mitochondrial stress and ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes. This thought-leadership analysis translates the evidence into practical assay strategy while defining the limitations that matter for translational interpretation.

• Ozone, Efferocytosis, and Neuropathic Pain

  2026-09-28

  Ruan et al. show that ozone reduces neuropathic pain in a chronic constriction injury model by enhancing macrophage efferocytosis through the AMPK/Gas6-MerTK/SOCS3 axis. The study links apoptotic-cell clearance to suppression of neuroinflammation and provides a mechanistic framework for evaluating efferocytosis as a therapeutic target.

• Rosiglitazone for PPARG Variant Assays

  2026-09-28

  Use Rosiglitazone to test whether a PPARG variant retains ligand-responsive activity—not just whether it changes adipocyte markers. A recent R212W study pairs receptor transcription with protein stability, mitochondrial function, and metabolic gene readouts, offering a practical blueprint for stronger type II diabetes research.

• Caspofungin Workflows for Candida Research

  2026-09-27

  Use Caspofungin to probe fungal cell-wall synthesis, benchmark antifungal susceptibility, and compare responses across Candida isolates. A practical workflow connects controlled in vitro testing with the delayed-treatment C. auris study—without confusing research findings with clinical recommendations.

• Cell Integrity Sets a Ploidy Limit in Budding Yeast

  2026-09-26

  Barker and colleagues show that budding yeast can reach approximately 32–64C ploidy after repeated genome replication, but cell-surface stress constrains this upper range. Their experiments link physical cell-surface conditions to ploidy tolerance, offering a framework for studying how cell size and integrity shape genome-doubling outcomes.

• Mdivi-1: Selective DRP1 Inhibitor Guide

  2026-09-25

  Mdivi-1 is a cell-permeable selective DRP1 inhibitor used to investigate mitochondrial fission, apoptosis, and mitochondrial dynamics research. Evidence from a hypoxia pulmonary hypertension study supports DRP1 as part of an endothelial-to-smooth-muscle signaling pathway, while product-dossier findings describe separate retinal and apoptosis models.

• Sulfo-NHS-LC-Biotin: Practical Labeling Guide

  2026-09-25

  Sulfo-NHS-LC-Biotin covalently labels accessible primary amines on proteins and peptides for detection or capture with avidin or streptavidin reagents. Its water solubility and membrane impermeability suit aqueous protein and cell-surface workflows, but it is not appropriate for intracellular or reversible labeling.

• Wnt agonist 1 for Wnt Pathway Research

  2026-09-24

  Use Wnt agonist 1 (BML-284) to probe β-catenin/TCF signaling in differentiation models and to test whether canonical Wnt activation changes a cancer-cell phenotype. A staged workflow separates direct pathway engagement from downstream effects such as platinum response, with practical controls and troubleshooting built in.

• AO/PI Double Staining Kit for Organoid Viability

  2026-09-24

  Use dual-fluorescence staining to distinguish viable, apoptotic-like, and membrane-compromised cells when evaluating glioma organoid responses. This workflow explains how to adapt the assay to complex samples, where dissociation, matrix carryover, and interpretation can otherwise obscure results.

• Coumestrol Drives PMAIP1-Linked Ferroptosis in RA FLS

  2026-09-23

  A recent cell-based study reports that Coumestrol suppresses proliferation and inflammatory output in rheumatoid arthritis fibroblast-like synoviocytes while promoting ferroptosis. Its proposed mechanism links reduced TRIM3-mediated protein turnover to increased mitochondrial PMAIP1 stability, although the findings do not yet establish efficacy in animals or patients.

• In Vitro Drug Response: Viability, Growth, and Cell Death

  2026-09-23

  Hannah R. Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. Its central contribution is a framework for separating growth inhibition from cell killing and interpreting their different proportions and temporal relationships in vitro.

• H2S Deficiency and ER Stress in Diabetic Cardiomyopathy

  2026-09-22

  The reference study links reduced endogenous hydrogen sulfide production with cardiac lipotoxicity and endoplasmic reticulum stress in diabetic cardiomyopathy. By combining patient samples, a diabetic rat model, and palmitate-treated AC16 cardiomyocytes, it shows that hydrogen sulfide supplementation or ER-stress inhibition reduces lipid accumulation and apoptosis-related injury.

• Coumestrol: RA Ferroptosis Assay Workflow

  2026-09-22

  Coumestrol provides a versatile research entry point for connecting estrogen receptor biology with fibroblast-like synoviocyte proliferation, inflammation, mitochondrial stress, and ferroptosis. This workflow translates the latest rheumatoid arthritis findings into practical cell-based assays while addressing solubility, dose interpretation, receptor crosstalk, and reproducibility.

• Ibrexafungerp Against Resistant Candida auris

  2026-09-21

  The reference study shows that ibrexafungerp retained in vitro activity against fluconazole-resistant Candida auris and improved outcomes in a neutropenic mouse model even when treatment began after infection was established. Its combination of glucan synthase targeting, oral administration, and efficacy with delayed therapy provides a useful benchmark for antifungal development and comparative Candida research.

8743 records 1/583 page Next 12345 下5页 Last page